Revere Residents Running for Cancer Research Forgione and Ustach to Participate in 122nd Boston Marathon

On April 16, Revere residents are running to conquer cancer as members of the Dana-Farber Marathon Challenge team in the 122nd Boston Marathon. Residents include:

Ryan Forgione

Thomas Ustach

 

Along with more than 500 Dana-Farber Marathon Challenge teammates from across the United States and around the world, they will run Massachusetts’ historic marathon route from Hopkinton to Boston to raise $5.5 million for cancer research at Dana-Farber Cancer Institute.

This year marks the 29th annual running of the Dana-Farber Marathon Challenge (DFMC). One hundred percent of the money raised by the Dana-Farber Marathon Challenge team goes to Dana-Farber’s Claudia Adams Barr Program in Innovative Basic Cancer Research that supports promising science research in its earliest stages. The Dana-Farber Marathon Challenge has raised more than $85 million for the Barr Program to date.

In 1990, Dana-Farber was among the first charity organizations to be recognized by the Boston Athletic Association (B.A.A), which organizes the Boston Marathon. The Dana-Farber Marathon Challenge team offers its members extensive fundraising support, training guidance from 1976 Boston Marathon men’s champion Jack Fultz, and team training runs, plus volunteer opportunities for non-runners. Dana-Farber Marathon Challenge runners who are not time-qualified for the Boston Marathon receive an invitational entry into the race.

Dana-Farber Marathon Challenge runners include cancer survivors and patients, and family and friends of those who have been affected by cancer.  Each team member must fulfill a basic fundraising commitment:

Invitational runners, runners who receive their entry from Dana-Farber, have a fundraising commitment of $5,000.

Own entry runners, runners who have joined the DFMC after obtaining their own race entry, have a fundraising commitment of $4,000.

A cornerstone of the Dana-Farber Marathon Challenge is its Patient Partner Program. Each year, approximately 50 current and former pediatric cancer patients of Dana-Farber’s Jimmy Fund Clinic are paired with DFMC runners as “Patient Partners.”  For the young patients, their partnerships with the runners provide a unique and friendly focus outside their illnesses. Another two dozen Partner Program families are paired with runners through the “In-Memory Program” in remembrance of their children’s brave struggle with the disease.

To contribute to the Dana-Farber Marathon Challenge, visit RunDFMC.org or contact the Dana-Farber Marathon Challenge office at (617) 632-1970 or [email protected] Follow DFMC on Facebook: www.facebook/marathonchallenge. On Twitter: #RunDFMC.

From achieving the first remissions in cancer with chemotherapy in 1948, to developing the very latest new therapies, Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment.  It is the only center ranked in the top 4 of U.S. News and World Report’s Best Hospitals for both adult and pediatric cancer care.

Dana-Farber sits at the center of a wide range of collaborative efforts to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy.  Dana-Farber/Brigham and Women’s Cancer Center provides the latest in cancer care for adults; Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for children. The Dana-Farber/Harvard Cancer Center unites the cancer research efforts of five Harvard academic medical centers and two graduate schools, while Dana-Farber Community Cancer Care provides high quality cancer treatment in communities outside Boston’s Longwood Medical Area.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.